Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Medicine

• Publication date

  2003-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.accreview.2003.10.072PMID 12935823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.

  2003cited by this paper
• Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice

  2003cited by this paper
• Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy.

  2002cited by this paper
• European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials.

  2002cited by this paper
• Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).

  2002cited by this paper
• Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.

  2001cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.

  2001cited by this paper
• Cardiac biomarkers for rapid evaluation of chest pain.

  2001cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.

  2000cited by this paper
• Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations

  2000cited by this paper
• Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management.

  1999cited by this paper
• Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.

  1999cited by this paper
• Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study

  1999cited by this paper
• Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban

  1999cited by this paper
• Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

  1999cited by this paper
• Long-term low-molecular-mass heparin in unstable coronary-artery disease : FRISC II prospective randomised multicentre study.

  1999cited by this paper
• Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.

  1999cited by this paper
• Angiographic findings in patients with refractory unstable angina according to troponin T status.

  1999cited by this paper
• Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group.

  1997cited by this paper
• Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group.

  1996cited by this paper
• Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

  1996cited by this paper
• Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I.

  1994cited by this paper
• The prognostic value of serum troponin T in unstable angina.

  1992cited by this paper

• Machine learning-based models to predict type 2 diabetes combined with coronary heart disease and feature analysis-based on interpretable SHAP

  2025cites this paper
• Machine learning-based models to predict one-year mortality among Chinese older patients with coronary artery disease combined with impaired glucose tolerance or diabetes mellitus

  2023cites this paper
• Cardiac Biomarkers

  2023cites this paper
• Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future

  2022cites this paper
• New Biomarkers of Cardiovascular Diseases (Literature Review). Part 1

  2021cites this paper
• Impact of combined baseline and postprocedural troponin values on clinical outcome following the MitraClip procedure

  2020cites this paper
• Systemic Cardiac Troponin T Associated With Incident Atrial Fibrillation Among Patients With Suspected Stable Angina Pectoris.

  2020cites this paper
• R/S ratio in lead II, and the prognostic significance of red cell distribution width in acute coronary syndrome

  2019cites this paper
• Biomarkers of Cardiac Stress and Injury in Athletes: What Do They Mean?

  2018cites this paper
• Cardiovascular stress biomarker assessment of middle-aged non-athlete marathon runners

  2018cites this paper
• Role of Highly Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

  2018cites this paper
• Challenges in using high-sensitive troponin reporting in clinical practice-The important role of appropriate use in the context of clinical evaluation.

  2017cites this paper
• Stable High-Sensitivity Cardiac Troponin T Levels and Outcomes in Patients With Chest Pain.

  2017cites this paper
• Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy

  2017cites this paper
• Survival and resource utilization in patients with chest pain evaluated with cardiac troponin T compared with high-sensitivity cardiac troponin T.

  2017cites this paper
• B-type Natriuretic Peptide and RISK-PCI Score in the Risk Assessment in Patients with STEMI Treated by Primary Percutaneous Coronary Intervention.

  2016cites this paper
• Ischemic Stroke with Troponin Elevation: Patient Characteristics, Resource Utilization, and In-Hospital Outcomes

  2016cites this paper
• Echocardiographic and biochemical analysis of cardiac function and injury among female amateur runners post-marathon

  2016cites this paper
• Cardiac troponin assays in the management of heart failure.

  2015cites this paper
• High sensitivity cardiac troponin assays in the clinical laboratories

  2015cites this paper
• Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician

  2015cites this paper
• Takotsubo

  2015cites this paper
• Comparison between HDL-c/TC and TG/HDL-c ratios for the prediction of dyslipidemia in troponin I positive patients

  2014cites this paper
• Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).

  2014cites this paper
• Elevated cardiac troponin T is associated with higher mortality and amputation rates in patients with peripheral arterial disease.

  2014cites this paper
• Prognostic Performance of Multiple Biomarkers in Patients with Non-ST Elevation Acute Coronary Syndrome: Analysis from MERLIN-TIMI 36

  2014cites this paper
• Non-ST-Elevation Acute Coronary Syndrome Prognosis

  2014cites this paper
• Prognostic Role of Serum Uric Acid in Critically Ill Patients with Non-ST Elevation Acute Myocardial Infarction

  2014cites this paper
• Osteopontin Is a Strong Predictor of Incipient Diabetic Nephropathy, Cardiovascular Disease, and All-Cause Mortality in Patients With Type 1 Diabetes

  2014cites this paper
• Excellence in acute cardiac care: an overview of the seminar proceedings

  2014cites this paper
• Combining whispering gallery mode lasers and microstructured optical fibers for in-vivo biosensing applications

  2013cites this paper
• High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

  2013cites this paper
• Cardiac Troponin T.

  2013cites this paper
• Cardiac troponin T: from diagnosis of myocardial infarction to cardiovascular risk prediction.

  2013cites this paper
• Speckle tracking derived strain in infants with severe perinatal asphyxia: a comparative case control study

  2013cites this paper
• Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners

  2013cites this paper
• Why all the struggle about CK-MB and PCI?

  2012cites this paper
• Anwendung von hochsensitiven Troponin-Tests beim Akuten Koronarsyndrom – Ein Überblick über den korrekten Einsatz, Stärken und Limitationen

  2012cites this paper
• 2 Cardiac Biomarkers

  2012cites this paper
• Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome.

  2012cites this paper
• Longitudinal studies of cardiac troponin I in a large cohort of healthy children.

  2012cites this paper
• Reduced cardiac output and its correlation with coronary blood flow and troponin in asphyxiated infants treated with therapeutic hypothermia

  2012cites this paper
• Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome

  2012cites this paper
• High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS

  2012cites this paper
• ESTUDIO DE MARCADORES BIOQUÍMICOS DE INTERÉS EN EL DIAGNÓSTICO Y PRONÓSTICO DEL SÍNDROME CORONARIO AGUDO.

  2011cites this paper
• Clinical diagnosis and outcomes for Troponin T ‘positive’ patients assessed by a high sensitivity compared with a 4th generation assay

  2011cites this paper
• Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction.

  2011cites this paper
• Troponin elevation in coronary vs. non-coronary disease.

  2011cites this paper
• Comparison between cardiac troponin I and CK-MB mass in acute coronary syndrome without st elevation.

  2011cites this paper
• New sensitive cardiac troponin assays for the early diagnosis of myocardial infarction.

  2011cites this paper
• Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes.

  2011cites this paper
• Antioxidant supplementation does not attenuate exercise-induced cardiac troponin release.

  2011cites this paper
• Sensitive and high sensitivity next generation cardiac troponin assays: more than just a name

  2011cites this paper
• When is the risk acceptable to proceed to noncardiac surgery following an acute myocardial infarction?

  2011cites this paper
• Clinical diagnosis and outcomes for Troponin T ‘ positive ’ patients assessed by a high sensitivity compared with a 4 th generation assay

  2011cites this paper
• Biomarkers in Acute Ischemic Heart Disease

  2011cites this paper
• Revascularization in Non–ST-Segment Elevation Acute Coronary Syndrome—For Whom, When, and How?

  2011cites this paper
• New features of troponin testing in different clinical settings

  2010cites this paper
• Theme: Advanced airway

  2010cites this paper
• Clinical Applications of Highly Sensitive Troponin Assays

  2010cites this paper
• Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay.

  2010cites this paper
• Novel biomarkers in cardiovascular disease: update 2010.

  2010cites this paper
• Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications.

  2010cites this paper
• Cardiac biomarkers in acute coronary syndromes: a review.

  2010cites this paper
• Perspective on the clinical application of troponin in heart failure and states of cardiac injury

  2010cites this paper
• Transient elevation of NT-pro-BNP as a predictor for myocardial ischemia

  2010cites this paper
• Diagnostic and Prognostic Information Provided by a High Sensitivity Assay for Cardiac Troponin T

  2010influential citation
• Diagnosing acute myocardial infarction with troponins: how low can you go?

  2010cites this paper
• DIAGNOSTIC AND PROGNOSTIC INFORMATION PROVIDED BY A HIGH SENSITIVITY ASSAY FOR CARDIAC TROPONIN T DIJAGNOSTI^KE I PROGNOSTI^KE INFORMACIJE KOJE PRU@A VEOMA OSETLJIVI TEST ZA SR^ANI TROPONIN T

  2010cites this paper
• Standardisation of cardiac troponin I measurement: past and present

  2010cites this paper
• Implementation of high sensitivity cardiac troponin T measurement in the emergency department.

  2010cites this paper
• DIAGNOSTIC AND PROGNOSTIC INFORMATION PROVIDED BY A HIGH SENSITIVITY ASSAY FOR CARDIAC TROPONIN T DIJAGNOSTI^KE I PROGNOSTI^KE INFORMACIJE KOJE PRU@A VEOMA OSETLJIVI TEST ZA SR^ANI TROPONIN T Jochen Jarausch

  2010influential citation
• Clinical performance of two highly sensitive cardiac troponin I assays.

  2009cites this paper
• Guías de prácticas de laboratorio clínico: Biomarcadores de síndromes coronarios agudos y falla cardíaca

  2009cites this paper
• High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice.

  2009cites this paper
• A sensitive cardiac troponin T assay in stable coronary artery disease.

  2009cites this paper
• Chapter 1 High-Sensitivity Troponin: A New Tool for Pathophysiological Investigation and Clinical Practice

  2009cites this paper
• Troponins and High-Sensitivity Troponins as Markers of Necrosis in CAD and Heart Failure

  2009cites this paper
• Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.

  2009cites this paper
• Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.

  2009cites this paper
• [Biomarkers in risk stratification of acute coronary syndrome without ST elevation: is there anything after troponin?].

  2009cites this paper
• Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention: An Analysis of Preintervention and Postintervention Troponin T Levels in 5487 Patients

  2008influential citation
• Cardiac troponin in cerebral injury: understanding your laboratory reports.

  2008cites this paper
• Impact of changing definitions for myocardial infarction: a report from the AMIS registry.

  2008cites this paper
• Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results.

  2008cites this paper
• Evaluating the role of elevated levels of troponin in acute ischemic stroke.

  2008cites this paper
• Cardiac troponin I measurement using the ACS:180 to predict four-year cardiac event rate

  2008cites this paper
• Prospective study of cardiac troponin I release in patients with upper gastrointestinal bleeding

  2008cites this paper
• Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice

  2008cites this paper
• Will new higher-precision troponins lead to clarity or confusion?

  2008cites this paper
• Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain

  2008cites this paper
• Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary InterventionCLINICAL PERSPECTIVE

  2008cites this paper
• The determination of the 99th centile level for troponin assays in an Australian reference population

  2008cites this paper
• Troponin revisited 2008: assay performance

  2008cites this paper
• Valor do fator natriurético tipo B e de outras variáveis como preditores de localização do território de isquemia miocárdica aguda e para avaliação prognóstica no infarto agudo do miocárdio sem supradesnivelamento do segmento ST

  2008cites this paper
• [Clinical importance of cardiac troponins].

  2008cites this paper
• Cardiac biomarkers in acute coronary syndromes

  2008cites this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cites this paper
• The effect of freezing and long-term storage on the stability of cardiac troponin T.

  2007cites this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cites this paper